HCA Healthcare, US40412C1018

HCA Healthcare stock stands at EUR 396.50 with USD 96.2 billion market value

Published on 10/08/2026 at 20:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC lifted its target from USD 435.00 to USD 496.00 on October 7, 2026. HCA Healthcare stock costs EUR 396.50 on October 8, 2026 after EUR 392.25.

Key points in brief

  • HCA Healthcare stock was EUR 396.50 at Lang & Schwarz on October 8, 2026, versus a prior close of EUR 392.25.
  • The stock had a USD 96.2 billion market capitalization and a price-to-earnings ratio of 14.87.
  • RBC Capital raised its HCA Healthcare target from USD 435.00 to USD 496.00 on October 7, 2026.
  • HCA Healthcare is scheduled to hold its third-quarter 2026 earnings call on October 27, 2026.
Architektur-Visualisierung eines geschwungenen Krankenhaus-Hochhauses mit Healing Garden bei Dämmerung
HCA Healthcare US40412C1018 CGI Architektur Render eines modernen Krankenhaus Towers mit Glasfassade bei Abenddämmerung, Illustration mit AI erstellt.

HCA Healthcare stock was last at EUR 396.50 at Lang & Schwarz on October 8, 2026 at 8:32 p.m. CEST, up 1.08 percent versus the prior close of EUR 392.25. HCA Healthcare had a USD 96.2 billion market capitalization at the same date, giving the price move a large-cap healthcare context.

Price and valuation

The Lang & Schwarz quote showed a bid of EUR 395.80 and an ask of EUR 397.20. The price was also last at USD 444.14 on the NYSE on October 8, 2026 at 2:34 p.m. ET, while the 52-week range in the same currency ran from USD 353.99 to USD 556.52.

HCA Healthcare traded 1.08 percent above its Lang & Schwarz prior close, while the finance quote showed a price-to-earnings ratio of 14.87 and a trailing dividend yield of 0.01 percent. Trading volume stood at 491,505 shares against an average volume of 1,466,375 shares on October 8, 2026.

Analyst target moves higher

Markets Insider reported on October 7, 2026 that RBC Capital raised its HCA Healthcare target from USD 435.00 to USD 496.00 and maintained an Outperform rating. The new target stood 11.69 percent above the NYSE price of USD 444.14 at the October 8 quote.

Comparison with peers

HCA Healthcare: plus 1.08 percent, P/E 14.87, market capitalization USD 96.2 billion
Tenet Healthcare Corporation (NYSE, USD): plus 0.58 percent, P/E 10.09, market capitalization USD 21.0 billion
Universal Health Services (NYSE, USD): plus 0.86 percent, P/E 7.23, market capitalization USD 10.7 billion

Next earnings date

HCA Healthcare is scheduled to hold its third-quarter 2026 earnings call on October 27, 2026, at 10:00 a.m. ET, according to the HCA Healthcare investor release dated September 30, 2026.

Stock quote remains the anchor

The euro quote, the NYSE value and the peer comparison place HCA Healthcare above both listed hospital operators on market capitalization and price-to-earnings ratio. The October 27 earnings date supplies the next fixed point for investors tracking whether the current valuation is supported by operating results.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.

HCA Healthcare stock data

  • Company: HCA Healthcare, Inc.
  • ISIN: US40412C1018
  • Ticker: HCA
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 8, 2026 at 8:32 p.m. CEST: EUR 396.50
  • Change versus prior close: plus 1.08 percent
  • Prior close Lang & Schwarz October 7, 2026: EUR 392.25
  • Market capitalization: USD 96.2 billion as of October 8, 2026
  • Price-to-earnings ratio: 14.87 as of October 8, 2026

Market context: Market report S&P 500.

More news and analyses on HCA Healthcare stock

Disclaimer...

en | US40412C1018 | HCA HEALTHCARE | boerse | 70269941 | bgmi